| DAO | diamine oxidase |
|---|---|
| DO | Doctor of Osteopathy (one of two fully recognized medical practioners in the US-the other being MD);... |
| dopase | dihydroxyphenylalanine oxidase |
| GO | gastro-[o]esophageal; geroderma osteodysplastica; gonorrhea; glucose oxidase |
| GOT | aspartate aminotransferase; glucose oxidase test; glutamate oxaloacetate transaminase; goal of treat... |
| reticuline oxidase | <enzyme> Vesicular plant enzyme that catalyses the formation of the berberine bridgehead carbon of scoulerine from the n-methyl carbon of reticuline; leads to benzophenanthridine alkaloids Registry number: EC 1.5.3.9 Synonym: berberine-bridge-forming enzyme, tetrahydroprotoberberine synthase, (s)-reticuline - oxygen oxidoreductase (methylene-bridge forming), berberine bridge enzyme, bbe enzyme (26 Jun 1999) |
|---|---|
| retina-specific amine oxidase | <enzyme> Genbank d88213 Registry number: EC 1.4.- Synonym: rao enzyme, human (26 Jun 1999) |
| menaquinol oxidase | <enzyme> Contains cytochrome aa3 Registry number: EC 1.10.2.- Synonym: mkh2 oxidase (26 Jun 1999) |
| rifamycin B oxidase | <enzyme> Converts rifamycin b to rifamycin o which spontaneously hydrolyzes to rifamycin s in neutral aqueous media Registry number: EC 1.10.3.- (26 Jun 1999) |
| cholesterol oxidase | <enzyme> An enzyme that catalyses the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidise other 3-hydroxysteroids. Chemical name: Cholesterol:oxygen oxidoreductase Registry number: EC 1.1.3.6 (12 Dec 1998) |
| methanol oxidase | <enzyme> Contains fad and flavin semiquinone; from the yeast hansenula polymorpha Registry number: EC 1.1.99.- (26 Jun 1999) |
| methyl sterol oxidase | <enzyme> Converts sterol 4-methyl to carboxylic acid; requires NADH or NADPH Registry number: EC 1.- Synonym: methyl sterol mixed function oxidase, 4-methyl sterol oxidase, methylsterol oxidase, 4alpha-methylsterol oxidase (26 Jun 1999) |
| phenol oxidase | <enzyme> An enzyme oxidizing benzenediols to semiquinones with O2. Synonym: monophenol monooxygenase, phenol oxidase, phenolase, polyphenol oxidase, urushiol oxidase. (05 Mar 2000) |
| phenylalanine oxidase | <enzyme> Forms phenylpyruvate in the presence of air; consider also phenylalanine dehydrogenase (nad) which requires nad Registry number: EC 1.4.3.- Synonym: phenylalanine desaminase, l-phenylalanine oxidase, phenylalanine dehydrogenase (26 Jun 1999) |
| phenylethylamine oxidase | <enzyme> Contains a quinone cofactor, possibly topa quinone; isolated from arthrobacter globiformis; genbank u03517 Registry number: EC 1.4.3.- (26 Jun 1999) |
| phenylpyruvate oxidase | <enzyme> Phenylpyruvate is converted to o-hydroxyphenyl-acetic acid Registry number: EC 1.- (26 Jun 1999) |
| phytanic acid alpha-oxidase | <enzyme> May be the genetic defect in refsum's disease Registry number: EC 1.14.99.- Synonym: phytanic acid alpha-hydroxylase (26 Jun 1999) |
| monoamine oxidase | <enzyme> Catalysing breakdown of several biogenic amines, such as serotonin, adrenaline, noradrenaline, dopamine. (18 Nov 1997) |
| monoamine oxidase inhibitor | <pharmacology> A drug that interferes with the action of monoamine oxidase, slowing the breakdown of certain neurotransmitters. Used in the treatment of depression. Monoamine oxidase inhibitors are a group of antidepressant drugs that prevent the activity of the enzyme monoamine oxidase in the central nervous system (brain) thus affecting mood. The use of these medications is often restricted due to their severe side effects and drug (and food) interactions. Examples include isocarboxazid, pargyline, selegiline, furazolidone and phenelzine. Acronym: MAOI (26 Mar 1998) |
| monoamine oxidase inhibitors | A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. Although mao inhibitors are probably as effective as tricyclic antidepressants in the treatment of major depression, the complex, sometimes severe, and often unpredictable interactions between mao inhibitors and many other drugs and food-derived amines make their medical use difficult and potentially hazardous. (12 Dec 1998) |